Skip to main content
. 2012 Apr 4;2(5):319–326. doi: 10.1016/j.jpha.2012.03.008

Table 2.

Stability samples result for telmisartan and amlodipine in human plasma (n=6).

Stability test Telmisartan Amlodipine
QC (spiked concentration, ng/mL) Mean±SD (ng/mL) Accuracy/stability (%) Precision (%) QC (spiked concentration, ng/mL) Mean±SD (ng/mL) Accuracy/stability (%) Precision (%)

Autosampler stability (at 10 °C for 48 h) 6.02 5.42±0.37 90.03 6.75 0.15 0.15±0.01 101.64 5.20
340.32 340.53±1.51 100.06 0.44 8.54 8.48±0.08 99.28 0.92



Wet extract stability (at 2-8 °C for 40 h) 6.02 5.72 ±0.23 94.95 3.97 0.15 0.16±0.01 104.63 3.74
340.32 338.88±2.31 99.58 0.68 8.54 8.47±0.06 99.24 0.76



Bench top stability (10 h) 6.02 5.98±0.22 99.31 3.62 0.15 0.15±0.01 100.58 3.64
340.32 340.12±1.85 99.94 0.54 8.54 8.51±0.08 99.64 0.92



Freeze–thaw stability 6.02 6.05 ±0.11 100.35 1.78 0.15 0.14±0.01 95.93 4.20
340.32 340.56±1.20 100.07 0.35 8.54 8.38±0.14 98.14 1.65



Reinjection stability (24 h) 6.02 6.05 ±0.13 100.10 2.18 0.15 0.15±0.01 101.09 3.55
340.32 340.09±1.41 99.86 0.41 8.54 8.51±0.07 102.00 0.86



Long-term stability (at −70 °C for 30 days) 6.02 5.86±0.26 96.96 4.48 0.15 0.15±0.01 100.43 6.92
340.32 340.00±1.95 99.83 0.57 8.54 8.46±0.10 101.44 1.19